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Abstract
 
Medicinal plants have been used since ancient times for the treatment of human ailments. Interest
in medicinal plants has been shown throughout the world because of the safe and effective constituents
of plant products. The increasing demand for herbal medicines, both in the developing and developed
countries, has provided the stimulus for the workers in this field  to maintain the quality and purity of
their herbal raw materials and finished products. The standardization problem relating to herbal drugs
arises from the complex composition of drugs that are used in the form of whole plants, plant parts or
extracts obtained there from. To ensure reproducible quality of any herbal remedy, proper control of
starting material is utmost essential. With this thought in mind, the present preliminary study was
conducted in order to discover the qualitative nature of 20 Traditional crude drugs available in the
commercial markets of Mumbai, Maharashtra, India.  
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Introduction
In India, the indigenous systems of medicine, namely Ayurvedic, Siddha and Unani, have been in
existence for several centuries. These traditional systems of medicine together with Homoeopathy and
Folklore medicine continue to play a significant role in the health care system of the population. Besides
the demands for medicinal plants made by these systems as their raw material, the demand for medicinal
plants made by the modern pharmaceutical industries has also increased manifold. Thus, medicinal plants
constitute a group of industrially important crops which bring appreciable income to the country by way
of export (Ganesan et al., 2006).
The majority of the medicinal and aromatic plants used by the herbal drug industry come from
wild collections. In Madagascar, for example, over 80% of the medicinal plants in that are used in this
trade come from wild collections. Similarly, about 90% of India’s medicinal plants supply to
international market is from wild stocks. Hardly 10% of raw materials come from cultivated sources,
which offer buyers more constituent quality and lower risk of adulteration than do their wild counterparts
(Handa, 2005).
The adulteration of market samples is one of the greatest drawbacks in promotion of herbal
products from India (Dubey, 2004). Plant samples in the market are stored under undesirable conditions
over the years and often contain a mixture of other plant species (Khatoon et al., 1993), thus adversely
affecting their bioefficacy. The efficacy of many of drugs is fading because of the adulterated, dried raw
materials profusely available in the indigenous market (Anon, 1996). With this view in mind, the present
preliminary study was conducted in order to discover the qualitative nature of Traditional crude drugs
available in commercial markets of Mumbai, Maharashtra, India.  
Materials and Methods
Collection and Identification of Crude drugs
   The common and locally available Ayurvedic crude drugs were collected from Mumbai commercial
markets. All samples were identified through comparison with standard references (The Ayurvedic
Pharmacopoeia of India, Part I, Vol.I.1989; Vol. II. 1999; Vol. III. 2001; Selected Medicinal Plants of
India, 1992; Nadkarni, 2002). Voucher specimens were photographed and archived at Welex
Laboratories Pvt. Ltd,                  Tarapur- 401506.
 Test for physiochemical parameters
   All samples were pulverized with the help of a stone pestle and mortar and sifted with an IS/0.300mm
sieve. Then, the fine powdered samples were stored in airtight polythene covers. The stored samples
were tested for purity and strength following the procedure described in The Ayurvedic Pharmacopoeia
of India.
Qualitative screenings of Phytochemicals
   The qualitative screenings of powdered crude drugs for their active ingredients were carried out using
the following standard procedures (Trease and Evans, 1983; Indian Pharmacopeias, 1996; Mukherjee,
2002; Horborne, 2005):   
Test for Alkaloids
Extract 2g of powdered drug by warming for 2 min. with 20ml 1% sulphuric acid in a 50ml
conical flask on a water bath, with intermittent shaking, centrifuge; pipette off the supernatant into a
small conical flask.
   Make an initial test for alkaloids by adding to 0.1 ml extract in a semi-micro tube, one drop of Meyer’s
reagent. It gives a cream precipitate with alkaloids.
 
Preparation of Mayer’s reagent:
It is prepared by dissolving 1.36g of mercuric chloride in 60 ml distilled water (A) and 5g of
potassium iodide in 60ml of distilled water (B). A and B are mixed together and the volume adjusted to
100ml with water.
Test for Essential oil / Volatile oil
Test 1.
Crush a small sample of the crude drug between the thumb and forefinger, and examine for the
presence of an odour.
   Observation: Drug containing volatile oils have a strong odour.
Test 2.
   Extract 1g of the powdered drug by warming with 10ml petroleum sprit (boiling point range 40-60 C.)
in a boiling tube heated on a water bath. Do not let the solvent boil dry. Filter the mixture into an
evaporating dish and concentrate the filtrate to about 1ml on a water bath. Using a pipette apply one drop
of the extract to a filter paper. Expose the paper to a current of warm air and note the occurrence of any
translucent area. If this observed, then oils are present.
Observation 1.
Place the paper in an oven at 105 C for 15min. and if the translucent spot can still be observed
after that time, then a fixed oil is present.
Observation 2.
The presence of a volatile oil is detected by the disappearance or diminution of the translucent
area.
 
Test for Flavonoids (flavone)
Test 1.
Prepare an aqueous filtrate of powdered drug, and take a portion of filtrate in a test tube, add 5
ml of dilute ammonia followed by add few drops of concentrated sulphuric acid. A yellow coloration is
appears. Upon further standing, the yellow coloration disappears.  
Test 2.
Take a small amount of powdered drug in a test tube, add 10 ml ethyl acetate and heat it over a
steam bath for 3min. then filter the mixture, take 4 ml of the filtrate with 1ml of dilute ammonia solution.
Observe the formation of yellow colouration. It is the indication of flavanoids compounds of drug.
Test for Glycosides
Test 1:
Extract 200 mg of the sample by warming in a test tube with 5ml of dilute (10%) sulphuric acid
(Test with PH paper) on a water bath at 100C for 2min. centrifuge or filter, pipette off the supernatant or
filtrate.
   Neutralize the acid extract with 5% solution of NaOH (Noting the volume of NaOH added).
   Add 0.1ml of Feling’s solution ‘A” and then Fehling’s solution ‘B’ until alkaline (Test with PH paper)
and heat on the water bath for 2min. Note the quantity of red precipitate formed and compare with that
formed in Test 2.
 
Test 2:
   Extract 200mg of the sample using 5ml of water instead of sulphuric acid. After boiling add a volume
of water equivalent to the volume of NaoH used in Test 1.
   Add 0.1ml of Fehling’s solution A and then Feling’s solution B until alkaline (test with PH paper) and
heat on the water bath for 2min. and note the quantity of red precipitate formed (Test.2.)
   Compare the quantity of precipitate formed in Test 2 with that formed in Test 1.  If the precipitate in
Test 1 is greater than that in Test 2, then glycosides may be present, since Test 2 represents the amount
of free reducing sugars already present in the crude drug, whereas Test 1 represents free reducing sugars
plus those released on acid hydrolysis of any glycosides in the crude drug.
Tests for Potassium Salts
Dissolve 0.1g  of  substance being examined in 2 ml of water. Heat the solution with 1ml of
sodium carbonate solution (10.6% w/v), no precipitate is formed. Add  0.05 ml of sodium sulphite
solution (10%), no precipitate is formed, cool in ice , add 2 ml of a 15% w/v solution of tartaric acid and
allow to stand, a white crystalline precipitate is produced. 
Test for Saponin
Take 2g of the powdered sample and boil with 20 ml of distilled water in a water bath and filter
it, 10 ml of filtrate is mix with 5 ml of distilled water and shake vigorously for a stable persistent froth.
To this froth mix 3 drops of olive oil and shake vigorously, then observe for the formation of emulsion.  
 
Tests for Starch
Take 1g of dry powder in 50 ml of water boil for one minute and cool, a thin and cloudly
mucilage is produced, which gives thick and more transparent mucilage.
To 10 ml of the mucilage add 0.05 ml of 0.01M Iodine, a dark blue colour is produced, which disappears
on heating and reappears on cooling.
Test for Tannins
Take 0.5g of the dried powdered sample in 20ml of water, boil on a water bath and filter it in a
test tube. Add few drops of 0.1% ferric chloride and observe for brownish green or a blue-black
colouration.
Test for Terpenoids (Salkowski test)
Take five ml of extract, mixed with 2 ml of chloroform, and concentrated H2SO4 (3ml) is added
to form a layer. A reddish brown colouration on the inner face is formed. It is indicates the presence of
terpenoids. 
 Test for Vitamin C or Ascorbic Acid
   To 2ml of 2% w/v solution, add 2ml of water, 0.1g of sodium bicarbonate and about 20mg of ferrous
sulphate, shake and allow stand; a deep violet colour is produced. Add 5ml of 1M sulphuric acid, the
colour disappears. 
Results and Discussion
   Identification of plants with botanical verifications is essential as contamination due to
misidentification of plant species or parts is common. Characterizing compound or biomarker is
identified from the plant part to assure the identity and quality of the preparation, this need not be
responsible for the therapeutic activity. Details including various names (binomial, vernaculars, etc.) with
collection conditions, and part to be used should be documented to ensure proper identification (WHO,
2001).    
In the present study, a total of 20 crude drugs were analyzed, 8 from root origins, 6 from fruits, 3
from leaves, 2 from stem bark and one from an insect gall. The details regarding the names of the plants
(Binomial), local name (Hindi), appearance, organoleptic test and location collection are enumerated in
Table-1.
The therapeutic potentials of plant and animal origins have been used from ancient times by a
simple process without the isolation of pure compounds (i.e. in the form of crude drugs or the galenicals
prepared from them). The pharmacological action of crude drug is determined by the nature of its
constituents (Mukherjee, 2002), such as alkaloids, terpenoids, flavonoids, glycosides, saponins, tannins,
etc.
A test requirement for foreign matter would ensure the extent of contamination of extraneous
matters, such as filth and other parts of botanicals not covered by the definition of the herbal drug. Since
sand and soil are predicable contaminations of botanicals, test requirements for total ash, water-soluble
ash, acid insoluble ash, residue on ignition and sulphated ash would be expected to limit such
contaminants (Handa, 2005).
   In the present study, among 20 crude drugs tested against purity and strength, all were soluble in water
and ethanol in different degree. Higher levels of water-soluble extractives were noticed only in 5 crude
drugs, viz., Emblica officinalis (50%), Pistacia integrima (40.8%), Picrorhiza kurroa (35.20%), Abies
webina (34%) and Glycyrrhiza glabra (30%). The lowest levels were found in Helecteres isora and
Tecoma undulata 8% in each. In ethanol soluble extractives, Emblica officinalis (40%) and Pistacia
integrima (32.8%) resulted in maximum levels of solubility (Table-2.). It may be due to the presence of
soluble nature of the compounds.
   In the total ash contents, Tribulus terrestris (14%) and Adhatoda vasica (12%) having higher level of
ash content and remaining drugs in the range of 4-10% of total ash. In acid insoluble contents of crude
drugs, Boerhaavia diffusa and Cyperus rotundus contain more amount (4%) and remaining drugs having
0.1 to 2% range (Table-2.).
   The identification of biologically active compounds is an essential requirement for quality control and
dose determination of plant based drugs. A medicinal herb can be viewed as a synthetic laboratory as it
produces and contains a number of chemical compounds. These compounds responsible for medical
activity of the herb are secondary metabolites (Dubey et al., 2004).
In the qualitative phytochemical screening, all the crude drugs have the main constituents (Table-
3). Among 20 drugs screened, 65% of drugs have tannins, 40% of drugs contain volatile or essential oils,
35% of drugs have glycosides and saponins. Alkaloids and starch are also present in 30% of drugs as a
main component. Mostly these are the very common ingredients of Ayurvedic medicinal drugs. Further
to confirm the presence of these active principles, quantitative analysis is essential. Hence at the time of
sampling of crude drugs from commercial markets, this qualitative analysis is necessary one.
The difference in the purity and strength of the crude drugs may be due to quantitative and
qualitative difference in the active principles or presence of compounds. As well as the nature of drugs
(young or mature parts), geographical location, condition of harvest, processing of drugs (sun dry, shade
dry, oven dry), storage etc., the amount and nature of active constituents is not constant throughout the
year. The age of the plant is also of considerable importance and governs not only the total quantity of
the active constituents produced, but also the relative proportions of the active principles (Evans, 2002
and Horonok, 1992).
It has been reported that the content of Taxol in Taxus baccata leaves and extracts stored at room
temperature for one year decreased by 30-40% and 70-80% respectively, while storage in a freezer and
out of direct sunlight produced no adverse deterioration (Das et al., 1998).
   Other reports indicated that the stored drug samples harbour mycotoxin producing fungi in high
frequency. Degradation of alkaloids and medicinally valuable secondary metabolites of stored plant
drugs due to fungal infestations has been reported (Horie et al., 1979; Narita et al., 1980; Roy and
Chaurasia, 1989). It would be, therefore, advisable to treat plant drugs with non-toxic chemicals at
various stages of storage and processing (Dubey et al., 2004). 
   Ideally the exact geographical source of a herbal material so much so the condition under which it has
been grown, harvested, dried and stored should be known, the chemical treatment such as pesticide or
fumigants used during harvesting or storing should be known. However, in many cases since the herbal
raw materials are obtained from varied geographical and commercial sources, the above conditions may
not be always known, for these reasons, therefore appropriate level of testing in addition to the
monograph criteria of any official book should be carefully assessed, based on various factors including
the nature of material, knowledge of its batch history and test result from previous batches (Mukherjee,
2002). Further test also carried out for the identification and quantification of active principles using
TLC and HPTLC methods with their marker compounds, comparison of these active compounds with
crude drugs collected from different geographical regions of India. 
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Table 1. List of Crude Drugs and their Description
 
S. No. Name of the
Sample
Local Name Appearance Organoleptic
Test
Location of
Market
1.  Abies webina Talispatra Dried leaves
with small
stem pieces
Mild
astringent with
Characteristic
odour
Mumbai
2.  Adhatoda vasica Vasaka Dried pieces
of leaves
Bitter Mumbai
3.  Boerhaavia diffusa Punarnava Dried entire
Root
Astringent
with
characteristic
odour
Mumbai
4.  Chichorium
indipus
Kasini Dried seeds Astringent Mumbai
5.  Clerodendrum Bharangimul Dried stem Mild Mumbai
indicum pieces astringent
6.  Cyperus rotandus Motha Dried entire
tubers
Mild bitter
with
characteristic
odour
Mumbai
7.  Emblica officinalis Avla Dried cut
pieces of
Fruits
Mild sour with
astringent Mumbai
8.  Glycyrrhiza glabra Yastimadhu Dried
Rhizome
Pieces
Sweetish
Mumbai
9.  Hedychium
spicatum
Kapurkachri Dried cut
pieces of
rhizome
Mild bitter
with
Characteristic
odour
Mumbai
10.  Helecteres isora Marodfali Dried entire
Fruits
Oily with
characteristic
odour
Mumbai
11.  Holarrhena
antidysentrica
Kutaj Dried pieces
of Bark
Strong bitter Mumbai
12.  Picrorhiza kurroa Kutki Dried pieces
of Rhizome
with Root
Strong Bitter
Mumbai
13.  Pimpinella anisum Saunf Dried Fruits Mild sweet
with
characteristic
odour
Mumbai
 
 
 
14.  
 
 
 
Pistacia
integerrima
 
 
 
Kakdashringi
 
 
 
Dried entire
Gall
 
 
 
Astringent
with mild
bitter
 
 
Mumbai
 
15.  
 
Smilax China
 
Chopchini
 
Dried cut
pieces of root
 
Astringent
with
characteristic
odour
 
Mumbai
16.  Tecoma undulata Rohitak Dried bark
pieces
Astringent
with
characteristic
odour
Mumbai
17.  Trachyspermum
ammi
Ajwayan Dried fruits Mild hot with
characteristic
odour
Mumbai
18.  Tribulus terrestris Gokhru Dried entire
Fruits
Astringent Mumbai
19.  Withania
somnifera
Ashwagandha Dried entire
Root
Mild bitter Mumbai
20.  Zingiber officinalis Sonth Dried
Rhizome
Mild hot with
Characteristic
odour
 
Mumbai
 Table 2. Purity and Strength of Crude Drugs.
 
S.
No.
Name of the
Sample
(Binomial)
PH*
Loss
On
Drying*
(%)
Water
Soluble
Extractive*
(%)
Ethanol
Soluble
Extractive*
(60%)
Total
Ash*
(%)
Acid
Insoluble
Ash*
(%)
1. Abies webina 5.37 8 34 16.8 6 1
2. Adhatoda vasica 8.82 18 28 13.5 12 1
3. Boerhaavia diffusa 6.48 10 9.6 10 10 4
4. Chichoriumindipus 6.20 10 9.6 3.2 8 1.5
5. Clerodendrumindicum 6.48 14 12 6 4 1
6. Cyperus rotandus 5.94 12 20 8 4 4
7. Emblica officinalis 3.28 18 50 40 7 2.5
8.
 
Glycyrrhiza
glabra 5.71 16 30 22 10 2
9. Hedychiumspicatum 6.47 20 20 11 8 1
10. Helecteres isora 6.68 16 8 10 10 1.5
11. Holarrhenaantidysentrica 5.37 12 22 18 6 1
12. Picrorhiza kurroa 5.22 16 35.20 17.60 7 1
13. Pimpinella anisum 6.16 16 15 8 8 1
14. Pistaciaintegerrima 4.01 16 40.8 32.8 7 0.1
15. Smilax China 5.63 8 20 7 10 2
16. Tecoma undulata 5.22 12 8 6.6 8 1
17. Trachyspermumammi 5.90 10 20 12.8 9 0.1
18. Tribulus terrestris 6.43 6 18.4 12 14 2
19. Withaniasomnifera 5.83 10 20.8 15 7 1
20. Zingiberofficinalis 3.51 22 25 15 6 1
 
* = Each value is a mean of Triplicates
Table 3. Screening of Active Principles of Crude Drugs.
 
S.
No.
Name of the
Sample
(Binomial)
Active
principle
 
Qualitative Tests
Alk1 Es/Vo Fla Gly Pos Sap Sta Tan Ter Vit.C
1. Abies webina Tannins,Essential oil + + - - - - - + - -
2. Adhatoda vasica
 
Vasicine
 
+ - - - - - - - - -
3. Boerhaaviadiffusa Alkaloid + - - - - - - - - -
4. Chichoriumindipus
Starch
 - - - - - - + - - -
5. Clerodendrumindicum
Glycosides,
Tannin,
Terpenoids
- - + - - + - + - -
6. Cyperusrotandus
Starch,
Saponins,
potassium
salts
- + - - + + + - - -
7. Emblicaofficinalis
 
Tannin,
Vitamin-C
- - - - - - - + -
 
+
 
 
 
8.
 
Glycyrrhiza
glabra Glycyrrhizin - - + + + + - + - -
 
9.
Hedychium
spicatum
Volatile oil,
Starch - + - - - - - + - -
10. Helecteres isora Saponin,Tannin - + - - - + - + - -
11. Holarrhenaantidysentrica
 
Conessine
 
+ - - + - - - + - -
12. Picrorhizakurroa
Kutkin,
Picrorhizin
 
- - - + - -  - - -
Flavonoids,
13. Pimpinellaanisum Saponin,Tannin
- + + - - - - + - -
14. Pistaciaintegerrima Tannin + + - + - - - + - -
15. Smilax China Saponin,Glycosides - - - + - + + + - -
16. Tecoma undulate Tannin,Saponin - - - + - + - + - -
17. Trachyspermumammi Volatile oil - + - - - - - + - -
18. Tribulusterrestris
Saponin,
Alkaloids + - - - + + + + - -
19. Withaniasomnifera Withanolides + - - + - - + - - -
20. Zingiberofficinalis Gingerol - + - - - - + - - -
 
Alk. - Alkaloids, Es/Vo. - Essential oil/Volatile oil, Fla. - Flavonoids, Gly. - Glycosides, Pos. - Potassium salts, Sap. - Saponin,
Sta. - Starch, Tan. - Tannins, Ter. - Terpenoids, Vit.C. - Vitamin-C.
+ = Presence of active principle.
 
 
 
 
 
 
 
 
